Carrier and Bioreactor Red Blood Cells for Drug Delivery and Targeting

Effect of membrane-active substances on carrier erythrocyte morphology, U. Sprandel and T. Kirschner; in vitro stability properties of crosslinked rat red blood cells, M. Pinilla et al; electroinsertion of proteins into red blood cells membrane - a novel method of drug targeting, Y. Mouneimne et al; performance of flow-regulated myocarium in pigs with normal, low, and high blood oxygen affinity, P. Ramo et al; human red blood cells (RBC) as bioreactors for the production and the release of fluoropyrimidine drugs from encapsulated pro-drugs, A. Gasparini et al; inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy, L. Rossi et al; effect of resealing temperature on carrier erythrocyte morphology, U. Sprandel and T. Kirschner; comparative dialysis encapsulation at different hypotonic pressures in human and rat erythrocytes, M.C. Tejedor et al; in vitro and in vivo methanol degradation by alcohol oxidase-loaded erythrocytes, A. Fazi et al; in vivo activation of adenylosuccinate lyase - pharmacological implications, C. Salerno and C. Crifo; encapsulation of hydrogenase into red blood cells for biochemical decompression, M.J. Axley et al; carrier red blood cells in cyanide antagonism, I. Petrikovics et al; in vitro evaluation of recombinant human interleukin 2 coated erthrocytes antibody targeted to T lymphocytes, H.J. Kirch et al; immunotherapeutic evaluation of human recombinant interleukin 2 (rIL2) coated erythocytes using the murine model, R.B. Moyes et al; organ distribution of glutaraldehyde treated erythocytes in patients with hepatic metastases, M. Tonetti et al; treatment of Rausher virus induced murine erythroblastic leukemia with rubomycin loaded erythrocytes, F.I. Ataullakhanov et al; erythrocytes as carriers of therapeutic enzymes in inherited metabolic diseases, U. Sprandel. (Part Contents).